Cargando…
Ethical issues in competing clinical trials
The proliferation of clinical trials in the last decade and the relatively limited number of experienced clinical trial sites in comparison has created in some sites an environment of clinical trial abundance. As clinical trial protocols typically restrict patients from concurrent clinical trial par...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461579/ https://www.ncbi.nlm.nih.gov/pubmed/31011656 http://dx.doi.org/10.1016/j.conctc.2019.100352 |
_version_ | 1783410499849814016 |
---|---|
author | Paquette, Miney Kelecevic, Julija Schwartz, Lisa Nieuwlaat, Robby |
author_facet | Paquette, Miney Kelecevic, Julija Schwartz, Lisa Nieuwlaat, Robby |
author_sort | Paquette, Miney |
collection | PubMed |
description | The proliferation of clinical trials in the last decade and the relatively limited number of experienced clinical trial sites in comparison has created in some sites an environment of clinical trial abundance. As clinical trial protocols typically restrict patients from concurrent clinical trial participation, and patients may be eligible for more than one trial at any given time, selecting the best trial for an individual patient requires evaluation of not only the merits of the individual trials but also patient preferences. This article highlights some potential ethical issues which should be considered when clinical trials are raised as a treatment option and when patients are eligible for more than one trial at the time of evaluation. |
format | Online Article Text |
id | pubmed-6461579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64615792019-04-22 Ethical issues in competing clinical trials Paquette, Miney Kelecevic, Julija Schwartz, Lisa Nieuwlaat, Robby Contemp Clin Trials Commun Article The proliferation of clinical trials in the last decade and the relatively limited number of experienced clinical trial sites in comparison has created in some sites an environment of clinical trial abundance. As clinical trial protocols typically restrict patients from concurrent clinical trial participation, and patients may be eligible for more than one trial at any given time, selecting the best trial for an individual patient requires evaluation of not only the merits of the individual trials but also patient preferences. This article highlights some potential ethical issues which should be considered when clinical trials are raised as a treatment option and when patients are eligible for more than one trial at the time of evaluation. Elsevier 2019-04-03 /pmc/articles/PMC6461579/ /pubmed/31011656 http://dx.doi.org/10.1016/j.conctc.2019.100352 Text en Crown Copyright © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Paquette, Miney Kelecevic, Julija Schwartz, Lisa Nieuwlaat, Robby Ethical issues in competing clinical trials |
title | Ethical issues in competing clinical trials |
title_full | Ethical issues in competing clinical trials |
title_fullStr | Ethical issues in competing clinical trials |
title_full_unstemmed | Ethical issues in competing clinical trials |
title_short | Ethical issues in competing clinical trials |
title_sort | ethical issues in competing clinical trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461579/ https://www.ncbi.nlm.nih.gov/pubmed/31011656 http://dx.doi.org/10.1016/j.conctc.2019.100352 |
work_keys_str_mv | AT paquetteminey ethicalissuesincompetingclinicaltrials AT kelecevicjulija ethicalissuesincompetingclinicaltrials AT schwartzlisa ethicalissuesincompetingclinicaltrials AT nieuwlaatrobby ethicalissuesincompetingclinicaltrials |